ClinicalTrials.gov
public full text
Public Domain
A Study of SIMPONI® to Arrest Beta-cell Loss in Type 1 Diabetes
The primary purpose of this study is to determine if golimumab can preserve beta-cell function in children and young adults with newly diagnosed Type 1 Diabetes (T1D).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Januvia on Beta Cell Function in Patients With Diabetes Mellitus#883677
- Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy#325258
- Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes#217171
- Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab#1032390
- Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults#914958
Record · ID 916488
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive